RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

GlaxoSmithKline PLC

A collection of news and information related to GlaxoSmithKline PLC published by this site and its partners.

Top GlaxoSmithKline PLC Articles

Displaying items 1-12
  • NIH to launch Ebola vaccine trials in humans

    NIH to launch Ebola vaccine trials in humans
    The National Institutes of Health has announced the first clinical trial of a vaccine to protect healthy people from infection by the Ebola virus, which is responsible for an estimated 1,550 deaths throughout West Africa. NIH Director Francis Collins...
  • A new era of testing [Commentary]

    A new era of testing [Commentary]
    Staffers passing by a room in the U.S. House of Representatives office building earlier this month did double takes. Whom they saw inside were no ordinary Capitol Hill briefing attendees: rats, mice, guinea pigs and rabbits. The presence of these...
  • Looking Out: Jurors can't be excluded based on sexual orientation, court says

    Looking Out: Jurors can't be excluded based on sexual orientation, court says
    In a decision with wide-reaching implications, a federal appeals court ruled this week that potential jurors cannot be left off of juries based on their sexual orientations. Remember the antitrust case involving two purveyors of HIV/AIDS drugs that...
  • Looking Out: Court deciding if sexual orientation can impact jury selection

    Looking Out: Court deciding if sexual orientation can impact jury selection
    Despite numerous marriage equality-related cases currently making their way through the judicial system, it's somehow the hot-button area of antitrust law where an important LGBT rights issue is taking place. The Associated Press reported Wednesday that...
  • Deals of the day -- mergers and acquisitions

    July 25 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** Dell Inc founder Michael Dell raised his $24.4 billion bid by less than 1 percent just hours before it was to be put to a vote,...
  • Things to know for Monday

    Things to know for Monday
    More than a dozen firefighters in Arizona died this weekend, political demonstrations in Brazil were suppressed by more than 10,000 troops, and Egypt is seeing resurgent political demonstrations of its own. Welcome to your post-weekend trends report for...
  • City to host summer series of outdoor movies, concerts [Old Town Laurel]

    The city of Laurel is hosting a series of movies and concerts during the summer on Fridays at Granville Gude Park, 8300 Mulberry St. Attendees are encouraged to bring a comfortable chair or blanket. All events are family friendly. The first movie, which...
  • Glaxo anti-cancer cocktail gets regulatory approval

    Glaxo anti-cancer cocktail gets regulatory approval
    After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...
  • Human Genome to lay off 97 workers

    Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...
  • State AG sues maker of diabetes drugs for false advertising

    State AG sues maker of diabetes drugs for false advertising
    Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
  • Consolidation wave poised to hit state's health care services, biopharma sectors

    Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...
  • Wealthy nations must follow through on disease fight

    Wealthy nations must follow through on disease fight
    In 1980, I moved my family from Maryland to the White Mountain Apache Reservation in Arizona to work on an issue most people are not comfortable talking about — diarrhea. At the time, diarrhea, which is preventable and treatable, was rampantly...